Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19

Condition:   COVID-19 Acute Respiratory Distress Syndrome Intervention:   Drug: Potassium Canrenoate Sponsors:   Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico;   University of Milan;   IRCCS Azienda Ospedaliero-Universitaria di Bologna Not yet recruiting

Source: ClinicalTrials.gov - July 27, 2021 Category: Research Source Type: clinical trials